Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 3/20 | 0.44 |
| ▸ | PLA2G7 | Q13093 | 3/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6977996 | 0.89 | MCL1 (0.39) | MAT2APLA2G7MCL1GABRA5GABRA1 | |
| SCHEMBL6979997 | 0.89 | MCL1 (0.42) | MAT2APLA2G7MCL1GABRA5GABRA1 | |
| Hydrochloric Acid SCHEMBL6973682 | 0.88 | MCL1 (0.39) | MAT2APLA2G7MCL1GABRA5GABRA1 | |
| SCHEMBL6979995 | 0.86 | MCL1 (0.44) | MAT2APLA2G7MCL1 | |
| SCHEMBL6981471 | 0.84 | GABRA5 (0.43) | MAT2APLA2G7GABRA5GABRA1ALDH1A1 | |
| SCHEMBL6980050 | 0.81 | GABRA1 (0.39) | MAT2AGABRA5GABRA1ALDH1A1MAPT | |
| SCHEMBL6979014 | 0.81 | GABRA1 (0.41) | GABRA5GABRA1ALDH1A1MAPT | |
| SCHEMBL6981678 | 0.81 | GABRA1 (0.46) | GABRA5GABRA1ALDH1A1MAPT | |
| SCHEMBL6981815 | 0.80 | GABRA1 (0.46) | GABRA5GABRA1ALDH1A1MAPT | |
| SCHEMBL7084095 | 0.79 | GABRA1 (0.36) | PLA2G7MCL1GABRA5GABRA1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0985671-B1 | PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT | MOCHIDA PHARM CO LTD (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-6197768-B1 | THERAPY, PREVENTION ISCHEMIC HEART DISEASE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| EP-0992240-A1 | THERAPEUTIC AGENT FOR ERECTION FAILURE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-12 | — | — | EP | disclosed |
| US-6018046-A | SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2000-01-25 | — | — | US | disclosed |